
Dry powder inhalers (DPI) differ among each other in many technical aspects, size and value of lung deposition as well as clinical efficacy of inhaled drugs. Easyhaler is a reservoir, multi-dose, high-resistance DPI and it is easy to operate. The device needs low inspiratory flows which are possible to achieve even by asthmatic children over 5-year-old and emitted dose and fine particle fraction are practically stable within the range of optimal inspiratory flows. Currently budesonid, formoterol and salbutamol are available in Easyhaler device form. Easyhaler is accepted by majority of patients with asthma or COPD.
Adult, Nebulizers and Vaporizers, Asthma, Bronchodilator Agents, Pulmonary Disease, Chronic Obstructive, Administration, Inhalation, Humans, Anti-Asthmatic Agents, Particle Size, Powders, Child
Adult, Nebulizers and Vaporizers, Asthma, Bronchodilator Agents, Pulmonary Disease, Chronic Obstructive, Administration, Inhalation, Humans, Anti-Asthmatic Agents, Particle Size, Powders, Child
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
